Integrated Filing — IndAS



General information about company

Scrip Code 500183
NSE Symbol HFCL
MSEI Symbol NOTLISTED
ISIN INE548A01028
Name of company HFCL LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 03-02-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 22-01-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Third quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 03-02-2026   12:00:00
End date and time of board meeting 03-02-2026   13:00:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 2
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not Applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 1,22,389.00 3,01,630.00
Other income 1,515.00 4,431.00
Total income 1,23,904.00 3,06,061.00
2 Expenses
(a) Cost of materials consumed 46,996.00 1,25,113.00
(b) Purchases of stock-in-trade 58,149.00 1,15,963.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (15,717.00) (21,671.00)
(d) Employee benefit expense 7,993.00 23,439.00
(e) Finance costs 5,475.00 15,546.00
(f) Depreciation, depletion and amortisation expense 3,692.00 9,647.00
(f) Other Expenses
1 Other Expense 9,422.00 27,448.00
Total other expenses 9,422.00 27,448.00
Total expenses 1,16,010.00 2,95,485.00
3 Total profit before exceptional items and tax 7,894.00 10,576.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 7,894.00 10,576.00
6 Tax expense
7 Current tax 1,746.00 1,746.00
8 Deferred tax 529.00 1,301.00
9 Total tax expenses 2,275.00 3,047.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 5,619.00 7,529.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 5,619.00 7,529.00
17 Other comprehensive income net of taxes (2,109.00) 1,251.00
18 Total Comprehensive Income for the period 3,510.00 8,780.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 15,302.00 15,302.00
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.39 0.52
Diluted earnings (loss) per share from continuing operations 0.39 0.52
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.39 0.52
Diluted earnings (loss) per share from continuing and discontinued operations 0.39 0.52
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Notes : 1. The above Un-audited Standalone & Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2025 have been reviewed and recommended by the Audit Committee and were approved by the Board of Directors of the Company at their respective meetings held on February 03, 2026. 2. The above Results are in compliance with the Indian Accounting Standards (Ind-AS) as prescribed under Section 133 of the Companies Act, 2013 read with the Companies (Indian Accounting Standards) Rules, 2021 (as amended). 3. (i) During the Financial year 2023-24, the Company had issued 5,10,14,491, equity shares of face value of Re. 1 each at an issue price of Rs.69/- per equity share (including premium of Rs.68/- per equity share), aggregating to Rs. 352.00 Crore approx. (including securities premium of Rs.346.90 Crore). The issue was made through eligible Qualified Institutions Placement (QIP) in terms of chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 as amended, Section 42 & 62 and other relevant provisions of the Companies Act, 2013. Out of the proceeds from QIP issue, the Company had utilized Rs. 313.05 Crore ( including share issue expenses) towards purposes/objects specified in the placement document. The balance amount of QIP proceeds amounting to Rs. 38.95 Crore remains in monitoring account with scheduled commercial bank as an interim use of funds. Further, the balance unutilized amount of Rs.38.95 crores, originally earmarked for capital expenditure in accordance with the Placement Document dated August 31, 2023, was to be utilized by July 31, 2025. The Board, at its meeting held on July 25, 2025, had approved an extension of the timeline for utilization of the said amount up to March 31, 2026. (ii) During the quarter ended 31st December, 2025, the Company has issued 8,79,29,651, equity shares of face value of Re. 1 each at an issue price of Rs.62.55/- per equity share (including premium of Rs.61.55/- per equity share), aggregating to Rs. 550.00 Crore approx. (including securities premium of Rs.541.21 Crore). The issue was made through eligible Qualified Institutions Placement (QIP) in terms of chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 as amended, Section 42 & 62 and other relevant provisions of the Companies Act, 2013. Out of the proceeds from QIP issue, the Company has utilized Rs. 399.39 Crore ( including share issue expenses) towards purposes/objects specified in the placement document during the current quarter ended 31st December 2025. The balance QIP proceeds amounting to Rs. 150.61 Crore remain invested in fixed deposit of Rs. 45.42 Crore and Rs. 105.19 Crore is lying in the monitoring and escrow account with scheduled commercial bank as an interim use of funds. 4. Pursuant to the notification issued by the Ministry of Labour & Employment on November 21, 2025, notifying the Code on Wages, 2019, the Industrial Relations Code, 2020, the Code on Social Security, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020 (collectively referred to as the Labour Codes), the Company has evaluated the impact of the said Codes on employee benefits. In accordance with Ind AS 19 Employee Benefits, the Company has recognized the resulting past service cost in respect of gratuity and compensated absences. Accordingly, an amount of Rs.8.46 crore on a standalone basis and Rs.8.91 crore on a consolidated basis has been recognized during the quarter ended December 31, 2025 and included under Employee benefit expense. 5. The Consolidated financial results for the third quarter and nine months ended December 31, 2025 includes the results of the following entities: a. HFCL Limited (HFCL) (Holding Company) b. HTL Limited (Subsidiary) c. Raddef Private Limited (Subsidiary) d. Moneta Finance Private Limited (Wholly owned Subsidiary) e. Polixel Security Systems Private Limited (Wholly owned Subsidiary) f. HFCL Advance Systems Private Limited (Wholly owned Subsidiary) g. DragonWave HFCL India Private Limited (Wholly owned Subsidiary) h. HFCL Technologies Private Limited (Wholly owned Subsidiary) i. HFCL Inc. United States of America, (Wholly owned Subsidiary) j. HFCL B.V. Netherlands, (Wholly owned Subsidiary) k. Nimpaa Telecommunications Private Limited (Jointly Controlled Entity) l. BigCat Wireless Private Limited (Jointly Controlled Entity) m. HFCL Canada Inc. Canada, (Wholly owned Subsidiary of HFCL B.V.- Netherlands) n. HFCL Poland Sp. z.o.o. (Formerly Blue Diwali Sp. z.o.o.), Poland, (Wholly owned Subsidiary of HFCL B.V.- Netherlands) (Voluntarily Liquidated and its name has been removed from National Court Register w.e.f. 02 January 2026) o. HFCL UK Limited, United Kingdom, (Wholly owned Subsidiary of HFCL B.V.- Netherlands) p. HFCL Pty Limited, Australia, (Wholly owned Subsidiary of HFCL B.V.- Netherlands) 6. Earning per share is not annualised for the quarter and nine months ended December 31, 2025, December 31, 2024 and quarter ended September 30, 2025 . 7. The figures of the previous periods have been re-grouped/ re-arranged wherever considered necessary. (Mahendra Nahata) Managing Director DIN 00052898 Place: New Delhi Date : 3rd February, 2026



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-10-2025 01-04-2025
Date of end of reporting period 31-12-2025 31-12-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Telecom Products 70,206.00 1,66,247.00
2 Turnkey Contracts and Services 52,183.00 1,35,383.00
3 Others 0.00 0.00
Total Segment Revenue 1,22,389.00 3,01,630.00
Less: Inter segment revenue 0.00 0.00
Revenue from operations 1,22,389.00 3,01,630.00
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Telecom Products 13,765.00 26,558.00
2 Turnkey Contracts and Services (1,110.00) (2,825.00)
3 Others 0.00 0.00
Total Profit before tax 12,655.00 23,733.00
i. Finance cost 5,475.00 15,546.00
ii. Other Unallocable Expenditure net off Unallocable income (714.00) (2,389.00)
Profit before tax 7,894.00 10,576.00
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Telecom Products 3,59,880.00 3,59,880.00
2 Turnkey Contracts and Services 3,72,277.00 3,72,277.00
3 Others 0.00 0.00
Total Segment Asset 7,32,157.00 7,32,157.00
Un-allocable Assets 89,350.00 89,350.00
Net Segment Asset 8,21,507.00 8,21,507.00
4 Segment Liabilities
Segment Liabilities
1 Telecom Products 1,13,580.00 1,13,580.00
2 Turnkey Contracts and Services 1,51,288.00 1,51,288.00
3 Others 0.00 0.00
Total Segment Liabilities 2,64,868.00 2,64,868.00
Un-allocable Liabilities 98,698.00 98,698.00
Net Segment Liabilities 3,63,566.00 3,63,566.00
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified to profit or loss (2,050.00) 1,222.00
Total Amount of items that will not be reclassified to profit and loss (2,050.00) 1,222.00
2 Income tax relating to items that will not be reclassified to profit or loss 2.00 36.00
3 Amount of items that will be reclassified to profit and loss
1 Items that will be reclassified to profit or loss (57.00) 65.00
Total Amount of items that will be reclassified to profit and loss (57.00) 65.00
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income (2,109.00) 1,251.00





Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising QIP
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 31-08-2023
Amount Raised 35,200.00
Report filed for Quarter ended 31-12-2025
Monitoring Agency Applicable
Monitoring Agency Name, if applicable Care Ratings Limited
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation Not Applicable
Comments of the Audit Committee after review No Comments
Comments of the auditors, if any No Comments
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Capital expenditure NA 7,500.00 0.00 3,605.00 0.00 Funds utilised during the quarter: Rs.3.74 Crores
2 Research and Development Expenditure NA 8,500.00 0.00 8,500.00 0.00
3 Repayment/prepayment of our short term borrowings NA 7,404.00 0.00 7,404.00 0.00
4 Funding Working Capital Requirements NA 7,500.00 0.00 7,500.00 0.00
5 General corporate purposes NA 3,346.00 3,365.00 3,365.00 0.00 The actual issue proceeds come to Rs.352 Crore approx. and as per placement document, the expenses related to the issue were estimated at Rs.9.50 Crores. However, the actual issue related expenses incurred as on December 31, 2023 were Rs.9.31 Crores. Accordingly, the balance unutilised Rs.0.19 Crore were already transferred to the Monitoring Account on December 30, 2023. During the quarter ended December 31, 2023, the utilisation of funds under the object General corporate purposes increased from estimated amount of Rs.33.46 Crore to Rs.33.65 Crore due to decline in actualization of issue expenses from the estimated issue expenses by Rs.0.19 Crore. Accordingly, the net issue proceeds allocated towards various Objects are Rs.342.69 Crore.


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (2)

Amount in (Lakhs)

Mode of Fund Raising QIP
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 24-12-2025
Amount Raised 55,000.00
Report filed for Quarter ended 31-12-2025
Monitoring Agency Applicable
Monitoring Agency Name, if applicable Care Ratings Limited
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation Not Applicable
Comments of the Audit Committee after review No comments
Comments of the auditors, if any No comments
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Capital expenditure towards purchase of Plant and Machinery: Expansion of Optical Fibre Cable NA 3,500.00 0.00 168.00 0.00 Funds utilised during the quarter : Rs.1.68 Cores
2 Funding expenditure towards Research and Development initiatives including acquisition of technologies NA 5,000.00 0.00 125.00 0.00 Funds utilised during the quarter : Rs.1.25 Cores
3 Repayment/prepayment of our long term / short term borrowings availed from banks / others NA 10,500.00 0.00 8,500.00 0.00 Funds utilised during the quarter : Rs.85 .00 Cores
4 Funding our long-term working capital requirements NA 26,000.00 0.00 21,458.00 0.00 Funds utilised during the quarter : Rs.214.58 Cores
5 General corporate purposes NA 9,300.00 0.00 9,025.00 0.00 Funds utilised during the quarter : Rs.90.25 Cores The actual issue proceeds come to Rs.550 Crore approx. and as per placement document, the expenses related to the issue were estimated at Rs.7 Crore. However, the actual expenses incurred as on December 31, 2025 are Rs.6.63 crore. The balance Rs.0.37 crore has been transferred to monitoring account. Accordingly, the net issue proceeds allocated towards various Objects is Rs.543 crore.


Signatory Details

Name of signatory MANOJ BAID
Designation of person Company Secretary and Compliance Officer
Place NEW DELHI
Date 03-02-2026